{
  "trial_id": "NCT01264315",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "off IV antibiotics and amphotericin for documented infections",
      "label": "met"
    },
    {
      "criterion": "patients should be CMV antigenemia negative",
      "label": "unknown"
    },
    {
      "criterion": "should have completed administration of any radiotherapy",
      "label": "met"
    },
    {
      "criterion": "The patient must have the capacity to give informed consent",
      "label": "met"
    },
    {
      "criterion": "Age >18 and < 65",
      "label": "met"
    },
    {
      "criterion": "If female, the patient is either postmenopausal since at least 24 consecutive months or surgically sterilized or she agrees to practice sexual abstinence or to use two reliable methods for contraception (e.g. a hormonal contraceptive, intra-uterine device, diaphragm with spermicide, condom with spermicide) for the duration of study",
      "label": "unknown"
    },
    {
      "criterion": "If male, the patient agrees to practice sexual abstinence or to use a latex condom during any sexual contact with women of childbearing potential for the duration of study",
      "label": "met"
    },
    {
      "criterion": "Negative pregnancy test",
      "label": "unknown"
    },
    {
      "criterion": "Newly diagnosed multiple myeloma patients with an HLA identical sibling suitable for PBSC donation and treated in induction with thalidomide or bortezomib or lenalidomide containing regimes",
      "label": "not_met"
    },
    {
      "criterion": "Complete cytogenetic analysis at diagnosis, including FISH analysis for chromosome deletions 13 and 17, and translocations (4;14) (11;14) and (14;16)",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Karnofsky score less than 60 (see appendix C), unless due solely to myeloma",
      "label": "triggers"
    },
    {
      "criterion": "Left ventricular ejection fraction less than 40%, or symptomatic coronary artery disease or other cardiac failure requiring therapy",
      "label": "triggers"
    },
    {
      "criterion": "Bilirubin greater than 2 X the upper limit of normal, or SGPT and SGOT > 4 X the upper limit of normal",
      "label": "unknown"
    },
    {
      "criterion": "DLCO < 40% (corrected) or receiving continuous supplemental oxygen.",
      "label": "triggers"
    },
    {
      "criterion": "Creatinine clearance < 40 cc/min at the time of initial autografting evaluation.",
      "label": "triggers"
    }
  ],
  "notes": "Patient has multiple myeloma with recurrent disease and systemic amyloidosis, on hemodialysis for ESRD. She was treated with various regimens including melphalan, prednisone, VAD, thalidomide, velcade, and pamidronate.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT01264315",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}